 |
PDBsum entry 4wqo
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
4wqo
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
148 a.a.
|
 |
|
|
|
|
|
|
|
104 a.a.
|
 |
|
|
|
|
|
|
|
96 a.a.
|
 |
|
|
|
|
|
|
|
141 a.a.
|
 |
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Insights into cullin-Ring e3 ubiquitin ligase recruitment: structure of the vhl-Elobc-Cul2 complex.
|
 |
|
Authors
|
 |
H.C.Nguyen,
H.Yang,
J.L.Fribourgh,
L.S.Wolfe,
Y.Xiong.
|
 |
|
Ref.
|
 |
Structure, 2015,
23,
441-449.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The von Hippel-Lindau tumor suppressor protein (VHL) recruits a Cullin 2 (Cul2)
E3 ubiquitin ligase to downregulate HIF-1α, an essential transcription factor
for the hypoxia response. Mutations in VHL lead to VHL disease and renal cell
carcinomas. Inhibition of this pathway to upregulate erythropoietin production
is a promising new therapy to treat ischemia and chronic anemia. Here, we report
the crystal structure of VHL bound to a Cul2 N-terminal domain, Elongin B, and
Elongin C (EloC). Cul2 interacts with both the VHL BC box and cullin box and a
novel EloC site. Comparison with other cullin E3 ligase structures shows that
there is a conserved, yet flexible, cullin recognition module and that cullin
selectivity is influenced by distinct electrostatic interactions. Our structure
provides a structural basis for the study of the pathogenesis of VHL disease and
rationale for the design of novel compounds that may modulate cullin-substrate
receptor interactions.
|
 |
|
|
|
|
 |